CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Exercise or conversion Chief Accounting Officer acquired 251 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Head of Research & Development sold 7,672 shares at $440.00 ($3,375,680)
- 4 Open-market sale Head of Glob Prod Strat & Com sold 3,087 shares at $440.00 ($1,358,280)
- 4 Open-market sale Director sold 360 shares at $274.17 ($98,701)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 14,473 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Research & Development gave up 3,510 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Accounting Officer gave up 115 shares (to pay taxes)
Page 14 of 86 · 1,714 filings